糖尿病冠状动脉粥样硬化性心脏病的发病机制及核素心肌灌注显像的研究进展

赵倩; 李娟

赵倩 , 李娟

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 3: (132-135)

引用本文:

Citation:

糖尿病冠状动脉粥样硬化性心脏病的发病机制及核素心肌灌注显像的研究进展

赵倩,
李娟^,

750004 银川, 宁夏医学院附属医院核医学科

通讯作者: 李娟, lijuan6161@yahoo.com.cn

中图分类号: R817.4

The progress of research on myocardial perfusion imaging in diabetic coronary disease

ZHA Qian,
LI Juan^,

Department of Nuclear Medicine, Affiliate Hospita of Ningxia Medical College, Yinchuan 750004, China

Corresponding author: LI Juan, lijuan6161@yahoo.com.cn

CLC number: R817.4

摘要: 糖尿病发病率不断升高,心血管系统病变是其主要并发症,冠状动脉疾病是导致糖尿病患者死亡的主要原因。负荷核素心肌灌注显像可早期诊断糖尿病患者中罹患心脏病者,判断预后及进行危险度分层,为早期防治糖尿病冠状动脉粥样硬化性心脏病提供依据,从而提高糖尿病患者生活质量、降低糖尿病冠状动脉粥样硬化性心脏病死亡率。
- 糖尿病 /
- 冠状动脉疾病 /
- 心肌 /
- 放射性核素显像
Abstract: The morbidity of diabetes mellitus is gradually increasing. It's most important complication is cardiovascular disease. The coronary disease is the main cause of death in patients with diabetes mellitus.The stress myocardial perfusion imaging help diagnose diabetic coronary disease and prognosis judgement and risk assessment. So it can improve the living standard of patients with diabetes mellitus, and decrease the mortality of diabetes mellitus.
- Diabetes mellitus /
- Coronary disease /
- Myocardium /
- Radionuclide imaging
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Young LH,Chyun DA.Heart disease in patients with diabetes.Porte DJ,Baron A,Sherwin RS,Eds.In Ellenberg and Rifkin's Diabetes mellitus:theory and practice.New York,McGraw-Hill,2002.823-844.
[2]	Alexander CM,Landsman PB,Teutsch SM.Diabetes mellitus,impaired fasting glucose,atherosclerotic risk factors,and prevalence of coronary heart disease.Am J Cardiol,2000,86(9):897-902.
[3]	Malmberg K,Yusuf S,Gerstein HC,et al.Impact of diabetes on longterm prognosis in patients with unstable angina and non-Q-wave myocardial infarction:results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry.Circulation,2000,102(9):1014-1019.
[4]	吴立玲.心血管病理生理学.北京,北京医科大学出版社,2000,1-11.
[5]	钱荣立·糖尿病与血脂异常.中国糖尿病杂志,2002,10 (2): 125-126.
[6]	Olexa P,Olexova M.Plasminogen activator inhibitor-1 (PAI-1),ischemic heart disease and diab-etes mellitus.Vnitr Lek,2003,49(3):222-226.
[7]	American Society of Nuclear Cardiology.Updated imaging guidelines for nuclear cardiology procedures,part 1.J Nucl Cardiol,2001,8(1):G5-G58.
[8]	Kapur A,Latus KA,Davies G,et al.A comparison of three radionuclide myocardial perfusion tracers in clinical practice:the ROBUST study.Eur J Nucl Med Mol Imaging,2002,29 (12):1608-1616.
[9]	Kumar R,Patel CD,Marwah A,et al.Detection of coronary artery disease by stress thallium scintigraphy in diabetic patients.Nucl Med Commun,2001,22(3):287-289.
[10]	Rajagopaian N,Miller TD,Hodge DO,et al.Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging.J Am Coll Cardiol,2005,45(1):43-49.
[11]	Miller TD,Rajagopaian N,Hodge DO,et al.Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes.Am Heart J,2004,147(5):890-896.
[12]	De Lorenzo A,Lima RS,Siqueira-Filho AG,et al.Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.Am J Cardiol,2002,90(8):827-832.
[13]	Berman DS,Kang X,Hayes SW,et al.Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men:impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol,2003,41(7):1125-1133.
[14]	Giri S,Shaw U,Murthy DR,et al.Impact of diabetes on the risk stratification using stress single-photon emission computed tomog-raphy myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease.Circulation,2002,105(1):32-40

[1]	韩萍萍 , 田月琴 . 放射性核素心肌灌注显像在急性冠状动脉综合征中的临床应用. 国际放射医学核医学杂志, 2008, 32(6): 336-340.
[2]	武志芳 . SPECT心肌灌注显像对糖尿病心肌缺血损伤的研究. 国际放射医学核医学杂志, 2004, 28(3): 105-108.
[3]	樊孝廉 , 舒毅 , 曾春平 , 靳仓正 , 鲁胜男 , 古炎发 , 车莉莉 , 张爱芳 . ⁹⁹Tc^m-MIBI门控心肌灌注显像在2型糖尿病无症状心肌缺血患者中的价值. 国际放射医学核医学杂志, 2016, 40(3): 171-174. doi: 10.3760/cma.j.issn.1673-4114.2016.03.002
[4]	朱灿胜 . 放射性核素显像在糖尿病足诊治中的应用. 国际放射医学核医学杂志, 2000, 24(4): 145-147.
[5]	邵晓梁 , 王跃涛 . 心肌灌注显像与冠状动脉钙化积分对冠心病风险评估的研究现状及相互关系. 国际放射医学核医学杂志, 2011, 35(2): 99-103. doi: 10.3760/cma.j.issn.1673-4114.2011.02.008
[6]	李军 , 刘兴党 . 分子显像在糖尿病及其并发症中的应用研究进展. 国际放射医学核医学杂志, 2022, 46(3): 174-179. doi: 10.3760/cma.j.cn121381-202007026-00159
[7]	杨波 , 刘长春 , 张勇 , 卢汝虹 . ⁹⁹Tc^m-MIBI运动负荷-静息心肌灌注显像对冠心病患者经皮腔内冠状动脉血管成形术的疗效评价. 国际放射医学核医学杂志, 2009, 33(1): 37-39. doi: 10.3760/cma.j.issn.1673-4114.2009.01.037
[8]	轩南 , 宋丽萍 . 双核素同步采集心肌显像技术的临床应用. 国际放射医学核医学杂志, 2007, 31(3): 151-154.
[9]	李薇 , 张宗耀 , 韩凯 , 王小迪 , 孙晓昕 . ⁹⁹Tc^m-PYP 双时相平面显像和断层显像在诊断转甲状腺素蛋白相关心脏淀粉样变中的临床应用价值. 国际放射医学核医学杂志, 2024, 48(1): 22-29. doi: 10.3760/cma.j.cn121381-202308025-00387
[10]	金玉新 . 双核素心肌SPECT的研究进展. 国际放射医学核医学杂志, 2003, 27(4): 171-173.
[11]	石洪成 . 心肌显像病人所致伪影的辨析及其对策研究. 国际放射医学核医学杂志, 2002, 26(1): 15-17.

点击查看大图

计量

文章访问数: 1464
HTML全文浏览量: 133
PDF下载量: 2

糖尿病冠状动脉粥样硬化性心脏病的发病机制及核素心肌灌注显像的研究进展

赵倩
李娟^,

通讯作者: 李娟, lijuan6161@yahoo.com.cn

750004 银川, 宁夏医学院附属医院核医学科

收稿日期: 2006-11-27

关键词:

摘要: 糖尿病发病率不断升高,心血管系统病变是其主要并发症,冠状动脉疾病是导致糖尿病患者死亡的主要原因。负荷核素心肌灌注显像可早期诊断糖尿病患者中罹患心脏病者,判断预后及进行危险度分层,为早期防治糖尿病冠状动脉粥样硬化性心脏病提供依据,从而提高糖尿病患者生活质量、降低糖尿病冠状动脉粥样硬化性心脏病死亡率。